Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

PALATIN TECHNOLOGIES, INC. Research and Development Expense

PALATIN TECHNOLOGIES, INC. (PTN) reported Research and Development Expense of $3.52 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-13

  • PALATIN TECHNOLOGIES, INC. research and development expense for the quarter ending 2026-03-31 was $3.52M, a 6.34% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. research and development expense for the quarter ending 2025-12-31 was $4.32M, a 25.96% increase year-over-year.
  • PALATIN TECHNOLOGIES, INC. research and development expense for the quarter ending 2025-09-30 was $2.53M, a 56.03% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. research and development expense for the quarter ending 2025-06-30 was $1.97M, a 57.83% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. research and development expense for fiscal 2025 was $14.90M, a 33.49% decline from fiscal 2024.
  • PALATIN TECHNOLOGIES, INC. research and development expense for fiscal 2024 was $22.40M, a 1.02% decline from fiscal 2023.
  • PALATIN TECHNOLOGIES, INC. research and development expense for fiscal 2023 was $22.63M, a 6.11% increase from fiscal 2022.
  • PALATIN TECHNOLOGIES, INC. research and development expense for fiscal 2022 was $21.33M, a 64.99% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-03-31$3.52M
10-Q · filed 2026-05-13
$7.84M
derived: sum of 2 quarters · filed 2026-05-13
$10.36M
10-Q · filed 2026-05-13
$12.33M
derived: sum of 4 quarters · filed 2026-05-13
2025-12-31$4.32M
10-Q · filed 2026-02-17
$6.85M
10-Q · filed 2026-02-17
$8.82M
derived: sum of 3 quarters · filed 2026-02-17
$12.57M
derived: sum of 4 quarters · filed 2026-05-13
2025-09-30$2.53M
10-Q · filed 2025-11-14
$4.50M
derived: sum of 2 quarters · filed 2025-11-14
$8.25M
derived: sum of 3 quarters · filed 2026-05-13
$11.68M
derived: sum of 4 quarters · filed 2026-05-13
2025-06-30$1.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$5.73M
derived: sum of 2 quarters · filed 2026-05-13
$9.15M
derived: sum of 3 quarters · filed 2026-05-13
$14.90M
10-K · filed 2025-09-23
2025-03-31$3.76M
10-Q · filed 2026-05-13
$7.18M
derived: sum of 2 quarters · filed 2026-05-13
$12.93M
10-Q · filed 2026-05-13
$17.60M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$3.43M
10-Q · filed 2026-02-17
$9.17M
10-Q · filed 2026-02-17
$13.85M
derived: sum of 3 quarters · filed 2026-02-17
$21.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-09-30$5.74M
10-Q · filed 2025-11-14
$10.42M
derived: sum of 2 quarters · filed 2025-11-14
$17.58M
derived: sum of 3 quarters · filed 2025-11-14
$23.13M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$4.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$11.83M
derived: sum of 2 quarters · filed 2025-09-23
$17.39M
derived: sum of 3 quarters · filed 2025-09-23
$22.40M
10-K · filed 2025-09-23
2024-03-31$7.16M
10-Q · filed 2025-05-14
$12.71M
derived: sum of 2 quarters · filed 2025-05-14
$17.73M
10-Q · filed 2025-05-14
$25.13M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$5.55M
10-Q · filed 2025-02-13
$10.57M
10-Q · filed 2025-02-13
$17.97M
derived: sum of 3 quarters · filed 2025-02-13
$22.80M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30$5.01M
10-Q · filed 2024-11-14
$12.42M
derived: sum of 2 quarters · filed 2024-11-14
$17.25M
derived: sum of 3 quarters · filed 2024-11-14
$21.62M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$7.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
$12.24M
derived: sum of 2 quarters · filed 2024-09-30
$16.60M
derived: sum of 3 quarters · filed 2024-09-30
$22.63M
10-K · filed 2024-09-30
2023-03-31$4.83M
10-Q · filed 2024-05-15
$9.20M
derived: sum of 2 quarters · filed 2024-05-15
$15.22M
10-Q · filed 2024-05-15
$22.66M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$4.37M
10-Q · filed 2024-02-14
$10.39M
10-Q · filed 2024-02-14
$17.83M
derived: sum of 3 quarters · filed 2024-02-14
$22.81M
derived: sum of 4 quarters · filed 2024-02-14
2022-09-30$6.03M
10-Q · filed 2023-11-14
$13.46M
derived: sum of 2 quarters · filed 2023-11-14
$18.44M
derived: sum of 3 quarters · filed 2023-11-14
$23.87M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$7.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
$12.42M
derived: sum of 2 quarters · filed 2023-09-28
$17.84M
derived: sum of 3 quarters · filed 2023-09-28
$21.33M
10-K · filed 2023-09-28
2022-03-31$4.98M
10-Q · filed 2023-05-15
$10.41M
derived: sum of 2 quarters · filed 2023-05-15
$13.89M
10-Q · filed 2023-05-15
$17.37M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$5.43M
10-Q · filed 2023-02-14
$8.91M
10-Q · filed 2023-02-14
$12.39M
derived: sum of 3 quarters · filed 2023-02-14
$14.90M
derived: sum of 4 quarters · filed 2023-02-14
2021-09-30$3.48M
10-Q · filed 2022-11-14
$6.97M
derived: sum of 2 quarters · filed 2022-11-14
$9.48M
derived: sum of 3 quarters · filed 2022-11-14
$13.49M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$3.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22
$5.99M
derived: sum of 2 quarters · filed 2022-09-22
$10.00M
derived: sum of 3 quarters · filed 2022-09-22
$12.93M
10-K · filed 2022-09-22
2021-03-31$2.51M
10-Q · filed 2022-05-16
$6.52M
derived: sum of 2 quarters · filed 2022-05-16
$9.44M
10-Q · filed 2022-05-16
$13.38M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$4.01M
10-Q · filed 2022-02-14
$6.94M
10-Q · filed 2022-02-14
$10.87M
derived: sum of 3 quarters · filed 2022-02-14
$14.51M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30$2.92M
10-Q · filed 2021-11-15
$6.86M
derived: sum of 2 quarters · filed 2021-11-15
$10.50M
derived: sum of 3 quarters · filed 2021-11-15
$13.76M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$3.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28
$7.57M
derived: sum of 2 quarters · filed 2021-09-28
$10.83M
derived: sum of 3 quarters · filed 2021-09-28
$13.96M
10-K · filed 2021-09-28
2020-03-31$3.64M
10-Q · filed 2021-05-14
$6.90M
derived: sum of 2 quarters · filed 2021-05-14
$10.03M
10-Q · filed 2021-05-14
$14.36M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$3.26M
10-Q · filed 2021-02-16
$6.39M
10-Q · filed 2021-02-16
$10.71M
derived: sum of 3 quarters · filed 2021-02-16
$14.66M
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30$3.13M
10-Q · filed 2020-11-16
$7.46M
derived: sum of 2 quarters · filed 2020-11-16
$11.40M
derived: sum of 3 quarters · filed 2020-11-16
$14.36M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$4.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25
$8.27M
derived: sum of 2 quarters · filed 2020-09-25
$11.23M
derived: sum of 3 quarters · filed 2020-09-25
$14.86M
10-K · filed 2020-09-25
2019-03-31$3.94M
10-Q · filed 2020-05-11
$6.91M
derived: sum of 2 quarters · filed 2020-05-11
$10.53M
10-Q · filed 2020-05-11
$15.82M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$2.96M
10-Q · filed 2020-02-10
$6.58M
10-Q · filed 2020-02-10
$11.87M
derived: sum of 3 quarters · filed 2020-02-10
$18.94M
derived: sum of 4 quarters · filed 2020-02-10
2018-09-30$3.62M
10-Q · filed 2019-11-12
$8.91M
derived: sum of 2 quarters · filed 2019-11-12
$15.98M
derived: sum of 3 quarters · filed 2019-11-12
$22.03M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$5.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12
$12.36M
derived: sum of 2 quarters · filed 2019-09-12
$18.40M
derived: sum of 3 quarters · filed 2019-09-12
$32.57M
10-K · filed 2019-09-12
2018-03-31$7.07M
10-Q · filed 2019-05-09
$13.11M
derived: sum of 2 quarters · filed 2019-05-09
$27.28M
10-Q · filed 2019-05-09
$31.42M
derived: sum of 4 quarters · filed 2020-09-25
2017-12-31$6.05M
10-Q · filed 2019-02-11
$20.21M
10-Q · filed 2019-02-11
$24.35M
derived: sum of 3 quarters · filed 2020-09-25
$33.41M
derived: sum of 4 quarters · filed 2020-09-25
2017-09-30$14.16M
10-Q · filed 2018-11-09
$18.31M
derived: sum of 2 quarters · filed 2020-09-25
$27.37M
derived: sum of 3 quarters · filed 2020-09-25
$35.50M
derived: sum of 4 quarters · filed 2020-09-25
2017-06-30$4.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25
$13.21M
derived: sum of 2 quarters · filed 2020-09-25
$21.34M
derived: sum of 3 quarters · filed 2020-09-25
$32.57M
10-K · filed 2020-09-25
$45.68M
10-K · filed 2017-09-25
2017-03-31$9.06M
10-Q · filed 2018-05-14
$17.20M
derived: sum of 2 quarters · filed 2018-05-14
$28.42M
10-Q · filed 2018-05-14
$38.95M
derived: sum of 4 quarters · filed 2018-09-13
2016-12-31$8.13M
10-Q · filed 2018-02-12
$19.36M
10-Q · filed 2018-02-12
$29.89M
derived: sum of 3 quarters · filed 2018-09-13
$40.56M
derived: sum of 4 quarters · filed 2018-09-13
2016-09-30$11.23M
10-Q · filed 2017-11-13
$21.75M
derived: sum of 2 quarters · filed 2018-09-13
$32.43M
derived: sum of 3 quarters · filed 2018-09-13
$43.70M
derived: sum of 4 quarters · filed 2018-09-13
2016-06-30$10.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13
$21.20M
derived: sum of 2 quarters · filed 2018-09-13
$32.47M
derived: sum of 3 quarters · filed 2018-09-13
$43.07M
10-K · filed 2018-09-13
2016-03-31$10.68M
10-Q · filed 2017-05-15
$21.95M
derived: sum of 2 quarters · filed 2017-05-15
$32.55M
10-Q · filed 2017-05-15
$42.32M
derived: sum of 4 quarters · filed 2017-09-25
2015-12-31$11.27M
10-Q · filed 2017-02-10
$21.87M
10-Q · filed 2017-02-10
$31.64M
derived: sum of 3 quarters · filed 2017-09-25
$39.23M
derived: sum of 4 quarters · filed 2017-09-25
2015-09-30$10.60M
10-Q · filed 2016-11-14
$20.37M
derived: sum of 2 quarters · filed 2017-09-25
$27.96M
derived: sum of 3 quarters · filed 2017-09-25
$32.23M
derived: sum of 4 quarters · filed 2017-09-25
2015-06-30$9.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25
$17.36M
derived: sum of 2 quarters · filed 2017-09-25
$21.64M
derived: sum of 3 quarters · filed 2017-09-25
$24.56M
10-K · filed 2017-09-25
2015-03-31$7.59M
10-Q · filed 2016-05-16
$11.86M
derived: sum of 2 quarters · filed 2016-05-16
$14.79M
10-Q · filed 2016-05-16
$17.38M
derived: sum of 4 quarters · filed 2016-09-19
2014-12-31$4.27M
10-Q · filed 2016-02-12
$7.20M
10-Q · filed 2016-02-12
$9.79M
derived: sum of 3 quarters · filed 2016-09-19
$11.94M
derived: sum of 4 quarters · filed 2016-09-19
2014-09-30$2.92M
10-Q · filed 2015-11-12
$5.52M
derived: sum of 2 quarters · filed 2016-09-19
$7.67M
derived: sum of 3 quarters · filed 2016-09-19
$10.30M
derived: sum of 4 quarters · filed 2016-09-19
2014-06-30$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-19
$4.75M
derived: sum of 2 quarters · filed 2016-09-19
$7.38M
derived: sum of 3 quarters · filed 2016-09-19
$10.83M
10-K · filed 2016-09-19
2014-03-31$2.15M
10-Q · filed 2015-05-12
$4.78M
derived: sum of 2 quarters · filed 2015-05-12
$8.23M
10-Q · filed 2015-05-12
$11.03M
derived: sum of 4 quarters · filed 2015-09-18
2013-12-31$2.63M
10-Q · filed 2015-02-12
$6.08M
10-Q · filed 2015-02-12
$8.87M
derived: sum of 3 quarters · filed 2015-09-18
$11.82M
derived: sum of 4 quarters · filed 2015-09-18
2013-09-30$3.45M
10-Q · filed 2014-11-14
$6.24M
derived: sum of 2 quarters · filed 2015-09-18
$9.19M
derived: sum of 3 quarters · filed 2015-09-18
$11.63M
derived: sum of 4 quarters · filed 2015-09-18
2013-06-30$2.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18
$5.74M
derived: sum of 2 quarters · filed 2015-09-18
$8.19M
derived: sum of 3 quarters · filed 2015-09-18
$10.53M
10-K · filed 2015-09-18
2013-03-31$2.94M
10-Q · filed 2014-05-12
$5.39M
derived: sum of 2 quarters · filed 2014-05-12
$7.73M
10-Q · filed 2014-05-12
$11.86M
derived: sum of 4 quarters · filed 2014-09-12
2012-12-31$2.45M
10-Q · filed 2014-02-14
$4.79M
10-Q · filed 2014-02-14
$8.92M
derived: sum of 3 quarters · filed 2014-09-12
$13.63M
derived: sum of 4 quarters · filed 2014-09-12
2012-09-30$2.34M
10-Q · filed 2013-11-13
$6.47M
derived: sum of 2 quarters · filed 2014-09-12
$11.18M
derived: sum of 3 quarters · filed 2014-09-12
$13.87M
derived: sum of 4 quarters · filed 2014-09-12
2012-06-30$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-12
$8.84M
derived: sum of 2 quarters · filed 2014-09-12
$11.53M
derived: sum of 3 quarters · filed 2014-09-12
$13.81M
10-K · filed 2014-09-12
2012-03-31$4.71M
10-Q · filed 2013-05-13
$7.40M
derived: sum of 2 quarters · filed 2013-05-13
$9.68M
10-Q · filed 2013-05-13
$12.90M
derived: sum of 4 quarters · filed 2013-09-27
2011-12-31$2.69M
10-Q · filed 2013-02-13
$4.98M
10-Q · filed 2013-02-13
$8.19M
derived: sum of 3 quarters · filed 2013-09-27
$9.92M
derived: sum of 4 quarters · filed 2013-09-27
2011-09-30$2.28M
10-Q · filed 2012-11-14
$5.50M
derived: sum of 2 quarters · filed 2013-09-27
$7.22M
derived: sum of 3 quarters · filed 2013-09-27
$9.21M
derived: sum of 4 quarters · filed 2013-09-27
2011-06-30$3.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27
$4.94M
derived: sum of 2 quarters · filed 2013-09-27
$6.92M
derived: sum of 3 quarters · filed 2013-09-27
$10.38M
10-K · filed 2013-09-27
2011-03-31$1.72M
10-Q · filed 2012-05-14
$3.71M
derived: sum of 2 quarters · filed 2012-05-14
$7.16M
10-Q · filed 2012-05-14
2010-12-31$1.98M
10-Q · filed 2012-02-14
$5.44M
10-Q · filed 2012-02-14
2010-09-30$3.45M
10-Q · filed 2011-11-14
2010-06-30$12.29M
10-K · filed 2012-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B